TY - JOUR
T1 - Molecular lesions in childhood and adult acute megakaryoblastic leukaemia
AU - Hama, Asahito
AU - Muramatsu, Hideki
AU - Makishima, Hideki
AU - Sugimoto, Yuka
AU - Szpurka, Hadrian
AU - Jasek, Monika
AU - O'Keefe, Christine
AU - Takahashi, Yoshiyuki
AU - Sakaguchi, Hirotoshi
AU - Doisaki, Sayoko
AU - Shimada, Akira
AU - Watanabe, Nobuhiro
AU - Kato, Koji
AU - Kiyoi, Hitoshi
AU - Naoe, Tomoki
AU - Kojima, Seiji
AU - Maciejewski, Jaroslaw P.
PY - 2012/2
Y1 - 2012/2
N2 - While acute megakaryoblastic leukaemia (AMKL) occurs in children with (DS-AMKL) and without (paediatric non-DS-AMKL) Down syndrome, it can also affect adults without DS (adult non-DS-AMKL). We have analysed these subgroups of patients (11 children with DS-AMKL, 12 children and four adults with non-DS-AMKL) for the presence of molecular lesions, including mutations and chromosomal abnormalities studied by sequencing and single nucleotide polymorphism array-based karyotyping, respectively. In children, AMKL was associated with trisomy 21 (somatic in non-DS-AMKL), while numerical aberrations of chromosome 21 were only rarely associated with adult AMKL. DS-AMKL was also associated with recurrent somatic gains of 1q (4/11 DS-AMKL patients). In contrast to trisomy 21 and gains of 1q, other additional chromosomal lesions were evenly distributed between children and adults with AMKL. A mutational screen found GATA1 mutations in 11/12 DS-AMKL, but mutations were rare in paediatric non-DS-AMKL (1/12) and adult AMKL (0/4). JAK3 (1/11), JAK2 (1/11), and TP53 mutations (1/11) were found only in patients with DS-AMKL. ASXL1, IDH1/2, DNMT3A, RUNX1 and CBL mutations were not found in any of the patient group studied, while NRAS mutation was identified in two patients with paediatric non-DS-AMKL.
AB - While acute megakaryoblastic leukaemia (AMKL) occurs in children with (DS-AMKL) and without (paediatric non-DS-AMKL) Down syndrome, it can also affect adults without DS (adult non-DS-AMKL). We have analysed these subgroups of patients (11 children with DS-AMKL, 12 children and four adults with non-DS-AMKL) for the presence of molecular lesions, including mutations and chromosomal abnormalities studied by sequencing and single nucleotide polymorphism array-based karyotyping, respectively. In children, AMKL was associated with trisomy 21 (somatic in non-DS-AMKL), while numerical aberrations of chromosome 21 were only rarely associated with adult AMKL. DS-AMKL was also associated with recurrent somatic gains of 1q (4/11 DS-AMKL patients). In contrast to trisomy 21 and gains of 1q, other additional chromosomal lesions were evenly distributed between children and adults with AMKL. A mutational screen found GATA1 mutations in 11/12 DS-AMKL, but mutations were rare in paediatric non-DS-AMKL (1/12) and adult AMKL (0/4). JAK3 (1/11), JAK2 (1/11), and TP53 mutations (1/11) were found only in patients with DS-AMKL. ASXL1, IDH1/2, DNMT3A, RUNX1 and CBL mutations were not found in any of the patient group studied, while NRAS mutation was identified in two patients with paediatric non-DS-AMKL.
UR - http://www.scopus.com/inward/record.url?scp=84855770637&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855770637&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.2011.08948.x
DO - 10.1111/j.1365-2141.2011.08948.x
M3 - Article
C2 - 22122069
AN - SCOPUS:84855770637
SN - 0007-1048
VL - 156
SP - 316
EP - 325
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 3
ER -